212 
Australian ASX listed Antisense can look to Isis & GSK deal for likley outcomes
Australian ASX listed Antisense can look to Isis & GSK deal for likley outcomes
Yale University lecture on antisense & siRNAAbout the Video
GlaxoSmithKline & Isis Pharmaceuticals announced a new strategic alliance that will apply the Isis antisense drug discovery platform to seek out & develop new therapeutics. A platform tech that has a similar approach to the Australian comapny Antisense.
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use